[10] [11] This risk is relevant to retatrutide given its significant weight-loss effect, and patients should be aware of related symptoms (see 'When to Seek Medical Advice' below)
The mechanism of action has not been fully elucidated, but it is thought that GHK-Cu may promote fibroblast proliferation resulting in collagen synthesis which may in turn promote increased scalp health and blood flow to hair follicles
Retinoic acid stimulates the synthesis of antimicrobial factors [8, 144]
Interestingly, tirzepatide, a dual-acting GIP/GLP-1 receptor agonist that is now clinically approved for both obesity and T2D, was designed with an amino acid sequence closely resembling that of native GIP, resulting in strong preference for GIPR binding over the GLP-1R
Could losing weight impair physical function in certain patient populations
Patients report that having a drug that shrinks their body and even occasionally their pain lets them breathe less fights every day with clothes, movement, and their self-image
